Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty

NCT02271399 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

156

Enrollment

OTHER

Sponsor class

Conditions

Venous Thromboembolism

Interventions

DRUG: acetylsalicylic acid
DRUG: rivaroxaban

Sponsor

Hanyang University Seoul Hospital